Suvretta Capital Management 13F holdings, Q1 2023
Holdings as of March 31, 2023 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 92 US equity positions worth $2.1bn in its Q1 2023 13F filing. The largest position was RPRX at 5.3% of the reported book, followed by HORIZON THERAPEUTICS PUB L and KURA. Against the Q4 2022 filing, it opened 11 new positions, added to 18 and reduced 13 among the top 50 holdings.
What did Suvretta Capital Management own in Q1 2023? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2022 |
|---|---|---|---|---|---|---|---|
| 1 | RPRX ROYALTY PHARMA PLC | Healthcare | 5.3% | $109.8m | 3,047,049 | 54% | added |
| 2 | HORIZON THERAPEUTICS PUB L | 5.1% | $106.3m | 973,755 | 11% | added | |
| 3 | KURA KURA ONCOLOGY INC | Healthcare | 3.9% | $80.4m | 6,573,335 | 3% | added |
| 4 | UNH UNITEDHEALTH GROUP INC | Healthcare | 3.8% | $78.1m | 165,164 | -36% | reduced |
| 5 | META META PLATFORMS INC | Communication Services | 3.6% | $75.1m | 354,198 | 44% | added |
| 6 | ARCELLX INC | 3.6% | $73.9m | 2,398,321 | 2% | added | |
| 7 | WYNN WYNN RESORTS LTD | Consumer Cyclical | 3.5% | $72.7m | 649,761 | -5% | reduced |
| 8 | ELV ELEVANCE HEALTH INC | Healthcare | 3.4% | $71.4m | 155,321 | 436% | added |
| 9 | INTRA-CELLULAR THERAPIES INC | 3.1% | $64.9m | 1,198,971 | 16% | added | |
| 10 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.9% | $61.1m | 622,916 | 29% | added |
| 11 | HLT HILTON WORLDWIDE HLDGS INC | Consumer Cyclical | 2.9% | $59.5m | 422,094 | -3% | reduced |
| 12 | AMZN AMAZON COM INC | Consumer Cyclical | 2.8% | $57.8m | 559,490 | – | new |
| 13 | EL LAUDER ESTEE COS INC | Consumer Defensive | 2.7% | $56.4m | 228,806 | -43% | reduced |
| 14 | CEG CONSTELLATION ENERGY CORP | Utilities | 2.7% | $55.2m | 702,609 | 63% | added |
| 15 | CL COLGATE PALMOLIVE CO | Consumer Defensive | 2.6% | $54.4m | 724,140 | 12% | added |
| 16 | BHVN BIOHAVEN LTD | Healthcare | 2.5% | $52.6m | 3,848,938 | 0% | held |
| 17 | YUM YUM BRANDS INC | Consumer Cyclical | 2.5% | $52.3m | 396,050 | – | new |
| 18 | INSM INSMED INC | Healthcare | 2.4% | $50.0m | 2,932,138 | 16% | added |
| 19 | UNP UNION PAC CORP | Industrials | 2.3% | $48.6m | 241,581 | -54% | reduced |
| 20 | 430 TERNS PHARMACEUTICALS INC | 2.0% | $40.8m | 3,448,275 | 0% | held | |
| 21 | CANADIAN PAC RY LTD | 1.9% | $38.4m | 498,810 | -35% | reduced | |
| 22 | NKE NIKE INC | Consumer Cyclical | 1.8% | $37.7m | 307,637 | -38% | reduced |
| 23 | 290A CHINOOK THERAPEUTICS INC | 1.8% | $36.3m | 1,568,797 | 9% | added | |
| 24 | PROK PROKIDNEY CORP | 1.7% | $36.1m | 3,193,175 | 0% | held | |
| 25 | ORCL ORACLE CORP | Technology | 1.6% | $34.1m | 366,513 | 2% | added |
| 26 | 89BIO INC | 1.6% | $33.7m | 2,210,536 | – | new | |
| 27 | MARINUS PHARMACEUTICALS INC | 1.6% | $33.3m | 4,831,261 | 0% | held | |
| 28 | STRO SUTRO BIOPHARMA INC | Healthcare | 1.3% | $26.3m | 5,689,086 | 2% | added |
| 29 | FIS FIDELITY NATL INFORMATION SV | Technology | 1.2% | $25.5m | 469,110 | -32% | reduced |
| 30 | XYZ BLOCK INC | Technology | 1.2% | $25.2m | 367,440 | -56% | reduced |
| 31 | PINS PINTEREST INC | Communication Services | 1.2% | $24.7m | 907,560 | – | new |
| 32 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.2% | $24.7m | 616,480 | -25% | reduced |
| 33 | SBUX STARBUCKS CORP | Consumer Cyclical | 1.2% | $24.2m | 232,761 | -48% | reduced |
| 34 | KEZAR LIFE SCIENCES INC | 1.0% | $21.6m | 6,887,591 | 97% | added | |
| 35 | WBD WARNER BROS DISCOVERY INC | Communication Services | 1.0% | $21.5m | 1,425,726 | – | new |
| 36 | PYPL PAYPAL HLDGS INC | Financial Services | 1.0% | $20.1m | 264,218 | – | new |
| 37 | COF CAPITAL ONE FINL CORP | Financial Services | 1.0% | $20.0m | 207,600 | – | new |
| 38 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.9% | $19.6m | 1,819,693 | 0% | held |
| 39 | GS GOLDMAN SACHS GROUP INC | Financial Services | 0.9% | $18.9m | 57,635 | – | new |
| 40 | COR AMERISOURCEBERGEN CORP | Healthcare | 0.9% | $17.8m | 111,458 | -11% | reduced |
| 41 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.8% | $15.6m | 1,983,179 | 85% | added | |
| 42 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.7% | $14.8m | 5,177,710 | 21% | added |
| 43 | ALVOTECH | 0.6% | $12.9m | 1,000,000 | 0% | held | |
| 44 | WFC WELLS FARGO CO NEW | Financial Services | 0.6% | $12.6m | 335,875 | – | new |
| 45 | MRVL MARVELL TECHNOLOGY INC | Technology | 0.6% | $12.5m | 289,300 | – | new |
| 46 | MTCH MATCH GROUP INC NEW | Communication Services | 0.5% | $11.4m | 296,801 | – | new |
| 47 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.5% | $10.8m | 1,902,643 | 0% | held |
| 48 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.5% | $10.4m | 454,000 | -34% | reduced |
| 49 | PEPG PEPGEN INC | Healthcare | 0.5% | $10.1m | 828,087 | 0% | held |
| 50 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.5% | $10.0m | 3,394,897 | 1% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.